RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price dropped 0.5% during mid-day trading on Wednesday . The stock traded as low as GBX 1.29 ($0.02) and last traded at GBX 1.30 ($0.02). Approximately 2,421,589 shares were traded during trading, an increase of 203% from the average daily volume of 799,335 shares. The stock had previously closed at GBX 1.31 ($0.02).
RTW Biotech Opportunities Price Performance
The company has a market cap of £5.03 million, a PE ratio of 3.62 and a beta of 0.60. The stock has a 50 day simple moving average of GBX 1.32 and a two-hundred day simple moving average of GBX 1.28.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- The 3 Best Fintech Stocks to Buy Now
- United Airlines Soars on Earnings Beat
- Airline Stocks – Top Airline Stocks to Buy Now
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
